Merck/Schering Zetia Has 50% Combo Use; Statin Of Choice Is Lipitor 

Prescriptions for Merck/Schering-Plough's Zetia during the drug's first six weeks on the market have been split equally between monotherapy and combination use with other cholesterol-reduction products